Interleukin 6 as a key regulator of muscle mass during cachexia
- PMID: 20871233
- PMCID: PMC3065300
- DOI: 10.1097/JES.0b013e3181f44f11
Interleukin 6 as a key regulator of muscle mass during cachexia
Abstract
Interleukin 6 (IL-6) has received significant attention for its regulatory role in muscle wasting during cachexia. This review examines the role of circulating IL-6 for decreasing muscle mass during cancer and emphasizes some of the indirect actions of IL-6 that may cause muscle wasting.
Figures
References
-
- U.S.D.o.H.a.H. Services, editor. 2008 Physical Activity Guidelines for Americans. U.S. Department of Health and Human Services; Washington, D.C.: 2008.
-
- al-Majid S, McCarthy DO. Resistance exercise training attenuates wasting of the extensor digitorum longus muscle in mice bearing the colon-26 adenocarcinoma. Biol Res Nurs. 2001;2:155–66. - PubMed
-
- Anderson EJ, Neufer PD. Type II skeletal myofibers possess unique properties that potentiate mitochondrial H(2)O(2) generation. Am J Physiol Cell Physiol. 2006;290:C844–51. - PubMed
-
- Baltgalvis KA, Berger FG, Pena MM, Davis JM, Carson JA. Effect of exercise on biological pathways in ApcMin/+ mouse intestinal polyps. J Appl Physiol. 2008;104:1137–43. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
